Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
At a time when Novo Nordisk (NOVN: N) has appeared to be slipping behind rival Eli Lilly (NYSE: LLY) and its blockbuster Zepbound (tirzepatide) in the race to be the frontrunner in obesity, the Danish pharma major has fought back with some compelling data on its product Wegovy (semaglutide injection)
The more common presentation is in a preexisting acquired or congenital nevus in which a focal bluish discoloration raises the possibility of malignant degeneration
Factors that may increase the likelihood of experiencing dizziness include: Rapid dose escalation without adequate titration Pre-existing cardiovascular conditions or autonomic dysfunction Concurrent use of medications that lower blood pressure or blood glucose Dehydration or inadequate fluid intake Older age or frailty Patients with type 2 diabetes using these medications may be at particular risk if they are also taking insulin or sulphonylureas, as the combination can increase the risk of hypoglycaemia, which commonly presents with dizziness or light-headedness
Physicochemical Profile Appearance: Bluetinted lyophilized powder (due to Cu coordination) Solubility: Soluble in aqueous buffers (mild acidic to neutral pH) Stability: Stable under dry, refrigerated conditions
US$ 21.91
US$ 21.85
US$ 27.02
US$ 21.61
US$ 21.25
US$ 24.34
